Oncology Central

Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials


During recent decades, major advances in the comprehension of biology and in biotechnologies have paved the way for what is commonly named personalized medicine. For cancer therapy, personalized medicine represents a paradigm shift in which patient treatment is based on biology in addition to histology and tumor location.

To view restricted content, please:

Leave A Comment